Study of Infrared Thermography in Diabetic Foot in Guadeloupe
ETPDG
2 other identifiers
observational
150
1 country
1
Brief Summary
It is hypothesized that thermal imaging differs between diabetic and non-diabetic individuals in Guadeloupe. Infrared thermography is also suggested as a useful tool for studying diabetic foot ulceration. The main objective is to compare the temperatures of four areas of the plantar surface of the foot among non-diabetic individuals, diabetic individuals, and diabetic individuals with foot ulceration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 27, 2024
CompletedFirst Submitted
Initial submission to the registry
June 11, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2026
CompletedJune 27, 2025
June 1, 2025
1.5 years
June 11, 2025
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
temperatures at four areas of the plantar surface of the foot
The primary outcome is the measurement of temperatures in degrees Celsius (°C) using infrared thermography (coupled with a 3D camera) at four areas of the plantar surface of the foot: the pulp of the hallux, the heel, the heads of the first and fifth metatarsals, and at the site of the diabetic foot ulcer.
baseline
Secondary Outcomes (1)
Temperatures on the same area of the contralateral foot
baseline
Study Arms (3)
non-diabetic individuals (control group)
Healthy volunteers will be recruited from the post-emergency consultation service of the ambulatory medicine platform at CHUG. These are patients attending for a follow-up evaluation after a previous visit to the emergency department.
diabetic individuals with diabetic foot ulceration
Diabetic patients with foot ulceration will be recruited during their visits to the multidisciplinary consultation at the Diabetic Foot Unit of the University Hospital of Guadeloupe, or during their hospitalizations in the orthopedic surgery department.
diabetic individuals without diabetic foot ulceration
Diabetic patients without foot ulceration will be recruited from the diabetes day hospital at CHUG, the ambulatory medicine platform at CHUG, and the diabetes therapeutic education program.
Eligibility Criteria
Healthy volunteers will be recruited from the post-emergency consultation service of the ambulatory medicine platform at CHUG. These are patients attending for a follow-up evaluation after a previous visit to the emergency department. Diabetic patients without foot ulceration will be recruited from the diabetes day hospital at CHUG, the ambulatory medicine platform at CHUG, and the diabetes therapeutic education program. Diabetic patients with diabetic foot ulceration will be recruited during their visits to the multidisciplinary consultation at the Diabetic Foot Unit of the University Hospital of Guadeloupe or during their hospitalizations in the orthopedic surgery department. Based on data from previous years, the active patient list consulting the Diabetic Foot Unit (UPPD) for foot ulceration is estimated to exceed 300 individuals.
You may qualify if:
- Adult patients
- Patients of Afro-Caribbean origin
- Volunteer patients free from pathology
- Person affiliated to or beneficiary of a social security scheme.
- Person who has agreed to sign a consent to participate in the study
- Adult patients
- Patients of Afro-Caribbean origin
- Type 1 or type 2 diabetic patients with and without diabetic foot ulceration
- Person affiliated to or beneficiary of a social security system.
- Person who has agreed to sign a consent to participate in the study
You may not qualify if:
- \- Minors
- patient with an active fracture or a history of fracture
- a history of legs surgery
- History of amputation
- Bilateral diabetic ulceration
- neurological disease (Parkinson, stroke, etc.)
- pregnancy
- Foot mycosis
- refusal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de La Guadeloupe
Pointe-à-Pitre, Guadeloupe
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanéva CHINGAN-MARTINO, MD
CHU de la Guadeloupe
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2025
First Posted
June 27, 2025
Study Start
September 27, 2024
Primary Completion
March 27, 2026
Study Completion
March 27, 2026
Last Updated
June 27, 2025
Record last verified: 2025-06